The Single-use Bioreactors Market is Projected to Reach $10.3 Billion by 2030, at a CAGR of 15.8% During 2023–2030, Says Meticulous Research®. Single-use bioreactors allow processors to implement disposable technology, such as single-use bags, in manufacturing upstream processes previously reserved for stainless steel equipment. These bioreactors are preferred over traditional stainless steel as autoclaving a traditional bioreactor can become a lengthy, costly, and inconsistent endeavor for pharmaceutical manufacturing processes. However, single-use or disposable bioreactors utilize pre-sterilized bioprocess bags as they greatly reduce the additional costs and time of sterilization. Featuring fewer moving parts than traditional bioreactors, single-use bioreactors are less expensive to maintain on the mechanical end and hence widely used by biopharma customers.
The growth of this market is mainly attributed to the booming biopharmaceutical market, the growing adoption of disposable technologies in the pharmaceutical and biotechnology industries, capacity expansions of biopharmaceutical plants, rising pharmaceutical R&D expenditures, the growing adoption of biosimilars, and the increasing prevalence of chronic diseases. Moreover, emerging economies and the rising adoption of personalized medicine and cell and gene therapies provide opportunities for the players in this market.
Here are the top 10 companies operating in the Single-use Bioreactors Market
Thermo Fisher Scientific Inc. (U.S.)
Founded in 1956 and headquartered in Massachusetts, U.S., Thermo Fisher offers products and services in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, government, and academic sectors. The company operates through four segments, namely, Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The company offers single-use bioreactors through the Life Sciences Solutions segment.
The company has a direct presence through its regional offices and production sites in various countries, including the U.S., Mexico, Brazil, Germany, Belgium, Austria, the U.K., Italy, the Netherlands, South Africa, UAE, India, China, Japan, Australia, and the Republic of Korea.
Danaher Corporation (U.S.)
Founded in 1984 and headquartered in Washington D.C., U.S., Danaher Corporation is primarily involved in designing, manufacturing, and marketing medical, professional, industrial, and commercial products and services for various end users. The company operates through four reportable business segments, namely, Biotechnology, Life Sciences, Diagnostics, and Environmental & Applied Solutions. The company offers single-use bioreactors through its subsidiary Cytiva under the Biotechnology segment.
The company has research and development, manufacturing, sales, distribution, service, and administrative facilities in more than 60 countries across the globe. Furthermore, it has a geographical presence in the U.S., China, Germany, Japan, and several other countries. Danaher Corporation sells its products through direct sales personnel and independent distributors.
Merck KGaA (Germany)
Founded in 1668 and headquartered in Darmstadt, Germany, Merck is a German healthcare and technology company that operates globally through its three major business segments, namely, Life Science, Healthcare, and Electronics. The Life Science business segment is further segmented into Research Solutions, Process Solutions, and Applied Solutions.
The Process Solutions sub-segment is engaged in offering single-use bioreactors products for various end users, such as academic institutions, government labs, pharmaceutical companies, R&D, and biotech organizations.
Eppendorf AG (Germany)
Founded in 1945 and headquartered in Hamburg, Germany, Eppendorf AG is a biotechnology company involved in developing, manufacturing, and commercializing products and services for laboratories. The company operates in four business segments, namely, Liquid Handling, Consumables, Separation and Instrumentation, and Lab Solutions. The company operates in the single-use bioreactors market through the Lab Solutions business segments.
The company operates in more than 30 countries globally. The company has a direct presence through its offices, sale subsidiaries, and facilities in Ireland, Belgium, the U.K., Poland, France, Austria, Denmark, Czechia, Russia, Spain, Italy, the U.A.E., India, Thailand, China, South Korea, Japan, Malaysia, the U.S., Brazil, and Australia, among others.
Sartorius AG (Germany)
Founded in 1870 and headquartered in Gottingen, Germany, Sartorius AG is a laboratory equipment supplier and pharmaceutical company providing laboratory and bioprocess solution products and services. The company operates in two reportable segments: Bioprocess Solutions Division and Lab Products & Services Division. The company operates in the biopharmaceutical processing equipment & consumables market through the Bioprocess Solutions Division. The company offers fermenters, bioreactors, filtration and purification products, chromatography systems, and columns & consumables, among others.
The company has a presence in more than 20 countries worldwide. The company has the largest Bioprocess Solutions facilities in Germany, France, and Puerto Rico. Beyond these locations, the Bioprocess Solutions Division also has manufacturing sites in the U.K., Switzerland, Tunisia, India, the U.S., China, Israel, and Slovenia.
Meticulous Research in its latest publication on Single-use Bioreactors Market has predicted the growth of 15.8% during the forecast year 2023-2030.
Solaris Biotechnology Srl (Italy)
Founded in 2002 and headquartered in Mantovano, Italy, Solaris Biotechnology Srl manufactures biotech, pharmaceutical, food & beverage, and dairy industry equipment. The company offers bioreactors, fermenters, cGMP solutions, and filtration systems. It also offers Clean-In-Place systems, consumables, and other related instruments.
The company has a direct presence in the U.S. through its subsidiary and in Malaysia through its sales & service facility. The company has more than 30 distributors operating all around the world. The only known subsidiary of the company operating in the bioprocessing market is Solaris Biotech USA (U.S.).
Cellexus International Ltd. (U.K.)
Founded in 2017 and headquartered in Scotland, U.K., Cellexus International Ltd. develops and manufactures the CellMaker range of single-use, airlift bioreactor systems and related technology. These products are used for cell culture and fermentation processes, helping its life sciences and pharmaceutical industries end users. The company offers bioreactors & accessories under the brand CellMarker based on airlift technology. This technology offers a particular way of aerating and mixing bioprocess to simplify, accelerate and improve cell culture, fermentation, and bacteriophage amplification. The company achieved ISO 9001:2015 certification.
Distek, Inc. (U.S.)
Founded in 1976 and headquartered in New Jersey, U.S., Distek, Inc. develops and manufactures laboratory testing instruments for the pharmaceutical and biotechnology industry. The company offers water bath and bathless dissolution, media preparation (heating, degassing and dispensing), in-situ fiber optic UV, bathless tablet disintegration and dissolution autosampling. The company’s bioprocessing portfolio includes the BIOne single-use bioreactor for cell culture applications and the BIOne 1250, an innovative bioreactor control system for mammalian and microbial models. The company provides these products to generic and biosimilar drug manufacturers, CROs, CMOs, cultured foods, Nutraceuticals, food & flavors, agriculture, beverage, and government agencies and universities.
The company provides products through various distributors in North America, Asia, Central America, the Middle East, Oceania, and South America.
CESCO Bioengineering Co., Ltd. (Taiwan)
Founded in 2002 and headquartered in Taichung, Taiwan, CESCO Bioengineering Co., Ltd. develops and manufactures cell culture products and services that help researchers and manufacturers in the biopharmaceutical industry. The company offers cell culture bioreactors, bioprocess equipment, consumables, and bioprocess platforms. The company offers these bioreactors under the name BelloCell and TideCell Systems.
PBS Biotech, Inc. (U.S.)
Founded in 2006 and headquartered in California, U.S., PBS Biotech, Inc. develops single-use manufacturing solutions for the cell therapy industry to enable broader access to novel regenerative medicines. The company offers Vertical-Wheel bioreactor systems and components. These products help in small-scale process development to large-scale clinical and commercial production.
Authoritative Research on the Single-use Bioreactors Market – Global Opportunity Analysis and Industry Forecast (2023-2030)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.